Parkside Psychiatric Hospital & Clinic

Parkside Psychiatric Hospital & Clinic offers Spravato treatment in Tulsa, Oklahoma for adults who have tried two or more antidepressants without enough relief. Spravato is a nasal spray form of esketamine approved by the FDA. Patients spray the dose themselves while a Parkside provider supervises, then stay at least two hours for monitoring.

Treatment usually starts at twice a week for four weeks. It then drops to once a week, and later to once a week or every other week. Care begins with an intake visit that confirms past medication history and sorts out insurance approval.

Patients can refer themselves, though a provider referral helps. Parkside serves Tulsa and northeastern Oklahoma.